Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

Low-quality generics are being sold at U.S. pharmacies, despite the FDA’s best efforts. In this webinar, experts reveal why the system is failing and the steps needed to drive real change in the generic drug marketplace.

Featuring

– Peter Baker, President, Live Oak Quality Assurance and Former FDA Inspector
– Rosemary Gibson, Author, China Rx: Exposing the Risks of America’s Dependence on China for Medicine
– John Gray, PhD, Dean’s Distinguished Professor, Department of Operations and Business Analytics, Ohio State University
– Suzanne Robotti, Founder and President, MedShadow Foundation

Investigating Generic Drugs is a webinar series for everyone who takes or prescribes medicine. Join this urgent public discussion with patients, doctors, pharmacists, researchers, and journalists to examine and improve generic drug safety.

INVESTIGATING GENERICS: America’s Overlooked Drug Crisis

November 3, 2025

INVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain

September 3, 2025

INVESTIGATING GENERICS: Healthcare Providers Call Out Issues With Generic ADHD Meds

DONATE:

Help fund our fight for improved medication safety and transparency by supporting our independent journalism.

Give Now

Want to feel more informed & empowered about medication decisions and whole-health alternatives?

No pharma ads. No political bias. Just straight up strong journalism.

Delivered directly to your inbox.

We seek to create a world where there are safer medications for all and where all people are fully informed about their medication benefits and side effects, using our explanatory and investigative journalism to both inform and stimulate public discussion to drive toward solutions.

Our Mission

MedShadow Foundation

Our Founder

WEBINARS

Learn about your medications and treatment options straight from independent experts.

WATCH

Follow Us On:

Download our App:

What is unbiased drug-safety journalism worth to you?

We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.

Donate to MedShadow

trigger

What is Unbiased Drug-Safety Journalism Worth to You?

We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.

As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.

trigger